Jiexin Zhang

17PUBLICATIONS
139CO-AUTHORS
Tumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jan 26, 2024
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial.

Edwin Roger Parra, Jiexin Zhang, Dzifa Yawa Duose

|May 15, 2023
Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer.

Edwin Roger Parra, Jiexin Zhang, Mei Jiang

|Apr 25, 2022
Chronic Exposure to Waterpipe Smoke Elicits Immunomodulatory and Carcinogenic Effects in the Lung.

Maya Hassane, Zahraa Rahal, Nareg Karaoghlanian

|Apr 20, 2022
Induction chemotherapy with or without erlotinib in patients with head and neck squamous cell carcinoma amenable for surgical resection.

Xiuning Le, Frederico O Gleber-Netto, M Laura Rubin

|Apr 08, 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC.

Pedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca

|Nov 18, 2021
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer.

Ming Chen, Runzhe Chen, Ying Jin

Pageof 3

Frequent Collaborators

13 joint publications

Jack J Lee

9 joint publications

Edwin Roger Parra

6 joint publications

Luisa Solis

6 joint publications

John Victor Heymach